Replies to post #626 on Oxford BioMedica PLC (OXBDF)

[georgejjl]

Expansion plans and fundraise
• Oxford BioMedica has identified premises to lease in Oxford close to its existing headquarters that are suitable for a new bioprocessing facility that will include:
• Four GMP suites
• Fill and finish facility
• Warehouse facility
• The lead facility in total is around 84,000 sqft (7,800 sqm)
• Planned Phase I and phase 2 expansion will fit into around 45,000 sqft (4,200 sqm) with space available for further future expansion
• Facility designs and costs have been determined through a third party design consultant
• Net fundraise proceeds £19.3m for capacity expansion
• Expansion creates the capacity to service this rapidly growing market that is expected to be worth $800 million annually by 2026.

http://www.oxfordbiomedica.co.uk/system/files/corporate-presentations/Prelims2017_AnalystPresentation_FINAL_0.pdf

Good luck and GOD bless,

George